Crucial Data Soutions

JUNE 27, 2022

Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, Business Development.

Business Development 52

Business Development Development Clinical Trials Clinical Trials 52

Pharmaceutical Technology

OCTOBER 12, 2022

New and existing investors including F-Prime Capital, Altitude Life Science Ventures, Mubadala Capital, Amgen, Exor Ventures, ARCH Venture Partners, Invus, Abu Dhabi Growth Fund (ADG), Newpath Partners, Polaris Partners, as well as other undisclosed investors have participated in the financing round.

Development 147

Development Life Science Clinical Trials Clinical Trials 147

Pharmaceutical Technology

OCTOBER 28, 2022

PTC Therapeutics has signed a strategic financing partnership worth up to $1bn with funds managed by Blackstone to back the development of the former’s innovative product pipeline. PTC will use the network and life sciences capabilities of Blackstone to expand its business development works.

Life Science 130

Life Science Business Development Development Production 130

pharmaphorum

NOVEMBER 7, 2022

1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to accelerate the design of small molecule and protein therapeutics, has appointed Patrick Genestin as chief business officer. .” Patrick Genestin, 1910 Genetics .

Life Science 105

Life Science Genetics Business Development Marketing 105

XTalks

JANUARY 25, 2023

In this week’s Xtalks Life Science podcast episode, Ayesha and the editorial team spoke with Susan Benton, Country Manager at Thea Pharma, an eye care company that focuses on developing innovative eye care treatments to help further the future of ophthalmic treatment. Susan Benton Country Manager Thea Pharma Inc.

Life Science 52

Life Science FDA Approval Business Development Production 52

Clinical Trial Gurus

OCTOBER 5, 2021

Oftentimes as clinical research professionals we do not think of ourselves as sales people but expanding your opportunities in the life sciences industry is as important as anything else we will ever do for our careers.

Clinical Research 52

Clinical Research Business Development Life Science Research 52

BioTech 365

NOVEMBER 3, 2021

180 Life Sciences Corp. Vu Chief Operating Officer/Chief Business Officer 180 Life Sciences Corp. Vu Chief Operating Officer/Chief Business Officer Highly Accomplished Strategy, Corporate/Business Development, Finance and Operations Executive With 20 Years of Biopharma … Continue reading →

Life Science 40

Life Science Business Development Development 40

Pharma Marketing Network

JUNE 17, 2021

The Healthcare Businesswoman’s Association Europe region released an update to its 2018 industry gender pay gap report that shows there is a clear increase in the pay gap between men and women in the life sciences sector in Europe. France and the U.K. reduced the pay gap to 4.8 percent and 5.1 Get the Full Report.

Life Science 52

Life Science Contract Manufacturing Business Development Clinical Research 52

pharmaphorum

DECEMBER 29, 2023

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.

Life Science 64

Life Science Business Development Development 64

XTalks

APRIL 26, 2023

He began his career in business development and commercial strategy roles at Genentech. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Cody Simmons, CEO, DermaSensor As a bioengineer and entrepreneur, Cody has spent all of his career bringing new health technologies to physicians and patients.

Life Science 52

Life Science Dermatology Clinical Trials Clinical Trials 52

Drug Channels

AUGUST 2, 2024

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey provides five crucial questions to help life science companies evaluate providers of patient support programs (PSPs).

Life Science 52

Life Science Business Development Marketing Development 52

FDA Law Blog

SEPTEMBER 26, 2023

(HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Jeff joins HP&M from Compliance Architects where he served as Vice President of Business Development.

Marketing 57

Marketing Life Science Business Development Compliance 57

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. We have been very impressed by their vision and the relevance of their platform.”.

Genome 102

Genome Genomics Medicine Development 102

pharmaphorum

JANUARY 25, 2023

Life sciences marketing has rapidly evolved to mirror that of consumer retail. It may not be surprising that the key to customer engagement optimisation, like many other processes within life sciences operations, is orchestrated data management and analysis. Automatic HCP segmentation HCPs change segments regularly.

Life Science 98

Life Science Sales Marketing Production 98

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects.

Medicine 147

Medicine Business Development Sales Life Science 147

FDA Law Blog

AUGUST 27, 2024

Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials—critical competencies for legal and business professionals in the biopharmaceutical sector. Everyone in the life sciences industry must be well-versed in the regulatory components and intellectual property nuances integral to patenting products.

Life Science 57

Life Science Business Development Regulation Production 57

XTalks

MAY 17, 2024

Xtalks spoke with Richard Philipson, MD, Chief Medical Officer (CMO) at Calliditas Therapeutics, a Sweden-based company with full commercial operations in the US focused on developing treatments for rare diseases to learn more about the continuing evolution of rare disease drug development.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

Pharmaceutical Technology

SEPTEMBER 6, 2022

The list includes, but is not limited to, the providers of shipping and logistics for medical devices, diagnostics and life science products, cold chain logistics, storage and terminal services, value-added and financial services, trucking options for manufacturers, and digitalised pharmaceutical supply chain for improved visibility.

Containment 147

Containment Pharmacy Life Science Production 147

Intouch Solutions

NOVEMBER 16, 2021

Breithaupt has been integral in building the media services department — hiring talent, developing media resources, and growing Intouch’s client roster, as well as evolving media capabilities and applying a pharma lens to her work. Collectively, Intouch Group employs more than 1,400 people.

Development 52

Development Life Science Packaging Packaging 52

FDA Law Blog

JULY 21, 2023

Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials AND a critical competency for legal and business professionals in the biopharmaceutical arena AT THE American Conference Institute’s (ACI’s) 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA ! This year’s co-chairs include Li Feng, Ph.D.

Life Science 52

Life Science Business Development Regulation Production 52

Cloudbyz

SEPTEMBER 16, 2021

Cloudbyz, a fast-growing integrated Clinical Research and development solution provider in Healthcare & Life Science, has recently executed a CSR drive at the Samarthanam Trust for the Disabled showcasing its commitment to social responsibility by giving back to the community. About the Cloudbyz.

Life Science 52

Life Science Development Clinical Trials Clinical Trials 52

pharmaphorum

NOVEMBER 17, 2020

So, working together with patients, research clinicians and Pfizer, the NIHR has collectively agreed a way in which it can facilitate patient engagement, remain aligned with ABPI and AMRC Codes and help to manage the burden faced by life sciences companies. How the NIHR’s Patient Engagement in Clinical Development service can help.

Clinical Trials 116

Clinical Trials Clinical Trials Trials Life Science 116

The Pharma Data

JANUARY 24, 2021

With this acquisition, Calibre Scientific bolsters its strength in the chromatography market and continues to broaden its life sciences presence in Europe. With the acquisition of AIT, Calibre Scientific gains a strategic partner to continue its growth in life sciences. LOS ANGELES, Jan. About Calibre Scientific.

Life Science 52

Life Science Reagent Production Manufacturing 52

pharmaphorum

FEBRUARY 1, 2022

David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. His research focuses on the development of big data machine learning for tracking the health of complex systems. Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Engineer 100

The Pharma Data

JANUARY 12, 2021

Ross is an accomplished life science sales leader with 18 years of experience in strategic account management, business development, and demonstrated excellence in leading cross-functional teams to develop commercial processes and best practices.

Life Science 40

Life Science Sales Production Business Development 40

pharmaphorum

OCTOBER 13, 2022

Together, they discuss the importance of VBI’s work in hepatitis B and glioblastoma, and some of the unique development and commercialisation challenges in the world of preventative vaccines. Lee Taurman is an experienced Life Sciences industry executive and management consultant. He also chaired GSK’s R&D Operating Board.

Vaccination 52

Vaccination Vaccine Life Science Development 52

The Pharma Data

JANUARY 12, 2021

13, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

pharmaphorum

APRIL 14, 2022

Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of oligonucleotides with case studies surrounding the discovery and development of oligonucleotide therapeutics as well as CMC and regulatory standpoints. CHAIRS FOR 2022: •Ekkehard Leberer, Senior Life Sciences Consultant, Elbicon.

RNA 52

RNA Clinical Trials Clinical Trials Life Science 52

XTalks

OCTOBER 7, 2024

Kelly Brassil, PhD, RN, FAAN Senior Director, Business Development Pack Health, a Quest Diagnostics company RWE is being used to expand drug labels to include broader patient populations often underrepresented in traditional studies. Yet, the strategic deployment of prospective studies can significantly enhance drug development.

Business Development 59

Business Development Drugs Development FDA Approval 59

pharmaphorum

SEPTEMBER 13, 2022

It’s all change at Alphabet’s life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman, who will have to decide how to spend the new money. Verily’s Andrew Conrad.

Life Science 75

Life Science Development Clinical Trials Clinical Trials 75

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. Basak, is a senior life sciences specialist at IFC, the arm of the World Bank Group investing in the private sectors in emerging markets.

Manufacturing 122

Manufacturing Marketing Vaccination Vaccine 122

pharmaphorum

DECEMBER 7, 2020

Wokingham, United Kingdom — 7 December 2020 — PRISYM ID, a leading provider of regulated content and label management solutions for the life sciences sector, announced today that PRISYM 360 version 1.10 has achieved SAP® certification using SAP Cloud Platform Integration Suite. – Ends – About PRISYM ID.

Life Science 52

Life Science Compliance Clinical Trials Clinical Trials 52

Client Pharma

DECEMBER 13, 2021

LOUISVILLE, KY — ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. Jeff Wiltrout, Ph.D., About TrialCard.

Clinical Supply 52

Clinical Supply Clinical Trials Clinical Trials Life Science 52

pharmaphorum

AUGUST 25, 2022

Once a staunch devotee of the diversified life sciences business model, Novartis has been steadily trimming down its focus in recent years, cashing in non-core business to generate billions of dollars and reinvesting the proceeds in its pharma R&D pipeline.

Sales 105

Sales Life Science Medicine Business Development 105

The Pharma Data

AUGUST 30, 2021

Malik succeeds John Young, Executive Vice President and Chief Business Officer, who recently announced his intent to retire after a 34-year career at Pfizer. Mr. Malik earned a Bachelor of Science in finance from Indiana University and currently serves on the University’s Kelley School of Business Dean’s Council.

Allergies 52

Allergies Life Science Business Development Development 52

pharmaphorum

JANUARY 12, 2023

The life sciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.

Drug Delivery 69

Drug Delivery Life Science Production Engineer 69

Pharmaceutical Technology

DECEMBER 22, 2022

The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.

Insulin 130

Insulin Production Development Genetics 130